Aspirin cuts skin cancer in women by up to 30%

Pinterest LinkedIn Tumblr +

aspirin adelaide nowWOMEN who take aspirin could reduce their risk of one of Australia’s deadliest cancers by up to 30 per cent, research has found.

A 12-year study of nearly 60,000 women aged 50-79 found the longer a woman took the common painkiller, the lower her risk of melanoma.

The findings suggest the anti-inflammatory effects of aspirin may help protect against the potentially deadly skin cancer, but experts warn existing sun safe practices including the use of sunscreen was the best way to prevent skin cancer.

The researchers concluded that aspirin, a nonsteroidal anti-inflammatory drug, “may have a chemoprotective effect against the development of melanoma”.

On average, the reduction in risk for all postmenopausal women taking aspirin was 21 per cent, while women who had taken the drug for five years or more reduced their risk by 30 per cent…Read more



About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.